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Abstract.  We have generated a  monoclonal antibody 
against a  synthetic peptide whose sequence was de- 
rived from the nucleotide sequence of a cDNA encod- 
ing od(XII) collagen.  The antibody, 75d7,  has been 
used to identify the ul(XII) chain on immunoblots of 
SDS-PAGE tendon extracts as a 220-kD polypeptide, 
under reducing conditions.  Amino-terminal  amino acid 
sequence analysis of an immunopurified cyanogen bro- 
mide fragment of type XII collagen from embryonic 
chick tendons gave a  single sequence identical to that 
predicted from the cDNA, thus confirming that the an- 
tibody recognizes the type XII protein.  Immuno- 
fluorescence studies with the antibody demonstrate 
that type XII collagen is localized in type I-containing 
dense connective tissue structures  such as tendons, 
ligaments,  perichondrium,  and periosteum.  With these 
data,  taken together with previous results showing that 
a portion of the sequence domains of type XII colla- 
gen is similar to domains of type IX, a nonfibrillar 
collagen associated with cross-striated fibrils in carti- 
lage,  we suggest that types IX and XII collagens are 
members of a distinct class of extracellular matrix pro- 
teins found in association with quarter-staggered  colla- 
gen fibrils. 
T 
HE extracellular  matrix molecules known as collagens 
represent a highly diverse group of proteins,  contain- 
ing molecules that range from the long rod-like fibril- 
lar collagens  (types I, II, III, V, and XI) to molecules that 
are either short or contain flexible domains (types IV and IX) 
(see reference 13). A recent addition to the collagens is type 
XII collagen which has been discovered by cloning  cDNA 
from chick embryonic tendon mRNA (6). Exhibiting partial 
similarity  to type IX collagen, the sequence of t~l(XII) has 
prompted the speculation (18) that type XII collagen may be 
associated with type I collagen containing  fibrils as type IX 
collagen is associated with type II-containing fibrils in carti- 
lage (5, 21, 22). The presence of type XII collagen as protein 
in embryonic tendons was confirmed by Dublet and van der 
Rest (3).  These investigators  isolated  pepsin-resistant  frag- 
ments from embryonic tendons and demonstrated that  the 
amino acid sequence of a tryptic peptide derived from one 
of these fragments  was  in  agreement with  the conceptual 
translation  product predicted from the nucleotide sequence 
of the type XII cDNA, pMG377 (3, 6). 
In this article we describe the generation  of a monoclonal 
antibody against  a synthetic  oligopeptide, whose sequence 
was derived from the nucleotide sequence of pMG377. This 
peptide  sequence  is  located  within  the  carboxy-terminal 
nontriple-helical domain of od(XII) chains, and it was selected 
because of its low level of similarity  with the corresponding 
domains in otl(IX) and ot2(IX) chains.  The monocional  anti- 
body, 75d7, has been used to identify the cd(XII) chain in ten- 
don extracts as a polypeptide of 220 kD, roughly twice the 
size of the od(IX) collagen chain. Amino acid sequence anal- 
ysis of immunopurified  cyanogen bromide fragments demon- 
strates that 75d7 indeed reacts with type XII collagen.  Immu- 
nofluorescence  studies  with this antibody demonstrate that 
type XII collagen is localized in type I-containing dense con- 
nective tissues such as tendons,  ligaments,  perichondrium, 
and periosteum. 
Materials and Methods 
Peptide Selection 
A sequence of 12-amino acid residues from within the 76-amino acid resi- 
due-long carboxy-terminal, nontriple-helical (NCI)  domain of od(XII) t 
was selected for antibody production. The peptide sequence derived from 
the nucleotide sequence of the cDNA pMG377 (6), FPEPYVPESGPYC, 
was selected based on its hydrophilicity characteristics calculated as de- 
scribed by Hopp and Woods (7), and a low level of similarity with other 
known collagen sequences.  The  carboxy-terminal cysteinyl residue was 
added for coupling purposes (10). 
Synthesis of  the Oligopeptide 
The peptide was synthesized by the solid-phase procedure of Merrifield (16) 
with the aid of an automated peptide synthesizer (model 990; Beckman In- 
1. In the original publication, describing the discovery of cd(XII) collagen 
(6), the length of the carboxy-terminal nontriple helical (NCI) domain of 
cd(XII) is given as 28-amino acid residues. However, we have recently rese- 
quenced both strands of the cDNA pMG377 and have discovered that an ex- 
tra nucleotide was incorrectly inserted in the original sequence close to the 
stop codon. By removing this nucleotide the open reading frame that defines 
NC1 does not end after 28-amino acid residues, but continues to include 
76-amino acid residues before a stop codon is reached. In this paper, the 
correct amino acid sequence of NC1 is indicated as part oftbe sequence in 
Fig. 3. 
2. Abbreviation used in this paper:  PVDE polyvinylidene difluoride. 
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from Peninsula Laboratories, Inc. (Belmont, CA) and coupled sequentially 
to a benzhydrylamine resin. The desired peptide was initially purified by 
filtration through  a  Sephadex  G-25  column  (4  x  60  cm),  previously 
equilibrated with 0.1  M  acetic acid. The remaining peptide fraction was 
pooled, lyophilized, and further purified by reverse phase HPLC. Separa- 
tion was obtained using an HPLC system (Beckman Instruments, Inc.) an 
ODS-3 (1  × 25 cm) semi-preparative column (Whatman Inc., Clifton, N  J). 
Buffer A was 0.05%  trifluoroacetic acid and buffer B was 0.05%  trifluoro- 
acetic acid in acetonitrile. The gradient was 20-30% B over 30 min at 2.0 
ml/min. The amino acid composition of the final peptide was determined 
with an analyzer (model 121MB Automatic; Beckman Instruments, Inc.), 
and the amino acid sequence was confirmed by automatic Edman degrada- 
tion (model 890M; Beckman Instruments, Inc.). The amino acid content 
found was +10% theoretical, and amino acid sequence analysis confirmed 
the peptide structure. 
Immunization and Antibody Production 
The synthetic peptide was coupled through the carboxy-terminal cysteinyl 
residue to keyhole limpet hemocyanin as described (10). Lyophilized, acti- 
vated peptide (5 nag) was coupled to 4  nag of hemocyanin (Polysciences, 
Inc., Warrington, PA) in 2 ml of 20 mM sodium phosphate buffer,  pH 7.5. 
After incubation at room temperature for 3 h, peptide-hemocyanin com- 
plexes were separated from uncoupled peptide by gel filtration on Sephadex 
G-50 (fine) (!  ×  25 cm) equilibrated with 20 mM sodium, pH 7.5. For 
generation of antibodies, 50-100 tzg of peptide-hemocyanin complex was 
mixed in 0.5 ml of complete Freunds adjuvant (Gibco Laboratories, Grand 
Island, NY) and injected intraperitoneally into Balb/c mice. Booster injec- 
tions were given at 2-wk intervals in incomplete Freunds adjuvant. A total 
of three to four booster injections were given. Mice were periodically bled 
from the tail vein for screening of sera. When sera were positive in ELISA 
against peptide-BSA conjugates, subcutaneous injections of 10-20/~g with- 
out adjuvant were given twice, one 5 d before fusion and the second 3 d 
before fusion. Mouse splenocytes were fused with P3 myeloma cells using 
standard methodologies. 
Immunoscreens 
Hybridoma supernatants were screened by a dot assay. BSA-peptide or em- 
bryonic chick tendon extracts were spotted onto nitrocellulose. The nitrocel- 
lulose filter was treated with 5% nonfat dried milk in PBS. Dots were then 
incubated for 1 h in 50 #l of supernatant. After rinsing in PBS (3  × 5 rain), 
the filters were incubated for 1 h in peroxidase-conjugated goat anti-mouse 
IgG (Boehringer Mannheim Biochemicals, Indianapolis, IN) in PBS con- 
taining 5%  normal goat serum. After additional washes, the membranes 
were treated with 3-3' diaminobenzidine (0.5  mg/ml) in  PBS containing 
H202  (0.03 %). 
Immunofluorescence was performed on 7-#m cryostat sections, which 
had previously been digested with testicular byalumnidase (3.3  mg/ml in 
phosphate buffer, pH 6.0) for 0.5 h at 37°C. Primary antibody, hybridoma 
culture supernatants or ascites fluid diluted 1:1,(300 (',,5.0/~g/ml), incuba- 
tions were for 1 h at room temperature. After washes (3  x  5 min), the sec- 
ondary antibody was applied (fluorescein-goat anti-mouse IgG, Boehringer 
Mannheim Biocbemicals). Culture supernatants from nonantibody produc- 
ing hybridomas were collected and used as negative control for primary an- 
tisera. Monoclonal antibodies against chicken types I, II, and type IX colla- 
gen were generously provided by Dr.  T.  Linsenmayer (Tufts University, 
Boston,  MA) and Dr.  R.  Mayne (University of Alabama, Birmingham, 
AL), respectively. 
Preparation of Collagen 
Leg tendons, dissected from 17-d chick embryos, were extracted for 24 h 
at 4°C, after homogenization, in 50 mM Tris-HCl, pH 8.0, containing I M 
NaCI and protease inhibitors (1  mM PMSF,  1 mM p-aminobenzamidine, 
10 mM N-ethylmaleimide, and 10 mM EDTA).  By immunoblotting analysis 
of SDS polyacrylamide slab gels, immunoreactive protein was found to be 
abundant in the  !  M  NaCI  soluble fraction. The  I  M  NaCI  extract was 
precipitated with ammonium sulfate, 40% saturation,  and the precipitate  was 
centrifuged (12,000 g, 20 min). The pellet was washed three times with 75 % 
ethanol containing 1.0% potassium acetate,  freeze dried, and kept at -20°C. 
Cyanogen Bromide Cleavage and Clostridiopeptidase A 
(EC 3.4.  24. 3) (Bacterial Collagenase) Digestion 
The washed ammonium sulfate pellet was suspended in 70%  formic acid 
and treated with CNBr (12 mg/ml), under nitrogen for 4  h at 30"C. The 
resulting solution was diluted 10x with water and freeze-dried. The CNBr 
peptides (6 mg/ml) were suspended in a solution of 50 mM Tris-HCI, pH 
7.6, 0.2 M NaCI and 5 mM CaCI2. The sample was then denatured by heat- 
ing at 100*C for 1 min. Aliquots were cooled and mixed with an equal vol- 
ume of bacterial collagenase (250 U/ml) (Advance Biofactures, Lynbrook, 
NY) in the same buffer made 10 mM in N-ethylmaleimide. Control samples 
were mixed with buffer alone. After 5 h at 37°C with occasional shaking, 
SDS was added to a final concentration of 2%. The sample was boiled for 
3 min and dialyzed against electrophoresis sample buffer. 
Gel Electrophoresis and Immunoblotting 
of Polypeptides 
SDS polyacrylamide slab gel electrophoresis was performed according to 
Laemmli (11) and samples were reduced with I%/3-mercaptoethanol. After 
electrophoresis, the gel was soaked in transfer buffer (10 mM 3-[cyclohexyl- 
amino]-l-pmpanesulfonic  acid, 10% methanol, pHi 1.0) for 5 min. The gel, 
sandwiched between a  sheet of immobilon  TM  polyvinylidene difluoride 
(PVDF)  2 membrane (Millipore Continental Water Systems, Bedford, MA) 
and several sheets of blotting paper (also equilibrated in transfer buffer), was 
assembled into a blotting apparatus (Trans-Blot  TM Cell; Bio-Rad Laborato- 
ries, Cambridge, MA) and electroblotted for 20 h at 60 V in transfer buffer 
(19). The PVDF membrane was reacted with antibody as described above. 
The collagen molecular mass markers (cyanogen bromide peptides of type 
I collagen) were stained with 0.1% Amido black in methanol/acetic acid/wa- 
ter (45:7:48)  for 10-15 min. The blots were then destained in methanol/ace- 
tic acid/water (45:7:48)  for 5-10 min. 
Results 
Monoclonal Antibodies against 1)~pe  XlI Collagen 
As a step in mapping the expression of type XII collagen we 
have chosen to develop a  monoclonal antibody  against an 
oligopeptide derived from the conceptual translation product 
of the cDNA pMG377. The selected target peptide has a se- 
quence from within the carboxyl nontriple-helical domain of 
cd(XII) (Fig. 1). The stretch of 12-amino acid residues in the 
peptide exhibits little or no similarity to sequences of known 
matrix proteins (including all other collagens). The synthetic 
oligopeptide was conjugated to keyhole limpet hemocyanin 
and used as an antigen to generate monoclonal antibodies. 
One antibody, 75d7, reacts with an epitope within the syn- 
thetic peptide and recognizes the native as well as SDS dena- 
tured antigen from tendons of chick embryos. In addition, it 
~MG721 
~377 
2400  400  200 
amino  acid residues  / / 
Figure 1.  Diagram showing the putative amino acid sequence do- 
main  structure  of type XII  collagen  partially  deduced  from  two 
overlapping cDNA clones (outlined in solid line).  The peptide se- 
quence from within the NC1 domain that was selected as target for 
monoclonal antibody production  is shown. The cysteinyl residue 
(C) at the carboxyl end of the peptide was added to facilitate cou- 
pling to hemocyanin. Also shown is the methionyl residue located 
at position  139 counted from the carboxyl end of cd(XIl) and the 
20-residue sequence after it. This 20-residue sequence is in perfect 
agreement  with the  amino  acid  sequence determined by  Edman 
degradation of the immunoisolated cyanogen bromide fragment of 
tendon type XII collagen. 
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dense connective tissues  (see below). 
Immunoblotting analysis of SDS polyacrylamide gels of 
1 M NaCl extracts of 17-d chick tendons revealed an immuno- 
reactive polypeptide with an apparent molecular mass of 220 
kD under reducing conditions (Fig.  2, lanes 1 and 5).  This 
immunoreactive polypeptide, which exhibited sensitivity to 
clostridiopeptidase  A  (bacterial  collagenase)  (Fig.  2,  lanes 
2  and  6),  we propose represents  the cd(XlI) chain.  While 
cd(I) and ct2(I) collagen chains, as well as a number of other 
proteins, are clearly visible in Coomassie-stained SDS-PAGE 
gels,  the antibody  75d7  exhibited  no  reactivity  with  these 
proteins.  In addition to the 220-kD polypeptide there is an 
immunoreactive band toward the top of the gel. Whether this 
very high molecular mass immunoreactive band represents 
od(XII) which has been cross-linked to another matrix mole- 
cule is currently under examination. 
To find out whether the antigen recognized by 75d7 in ten- 
don extracts is indeed cd(XII), we have examined the prod- 
ucts of cyanogen bromide cleavage of tendon extracts for im- 
munoreactive peptides.  There  are  four methionyl  residues 
within the pMG377-derived sequence. These residues are lo- 
cated at amino acid residue positions  15,  24,  40,  and  139, 
counted from the carboxyl end of cd(XII) (see Fig. 3).  The 
75d7 epitope is located between residues 51 and 63 (Fig. 3). 
Thus, treatment of od(XII)-containing tissues with cyanogen 
bromide  should  release  a  99-residue-long  immunoreactive 
fragment. This fragment contains the two cysteinyl residues 
Translated  sequence of carboxyl end of el(XH) 
GFQGPPGERGMPgE.KG_ERGTG_SC~_PR_GL_PGP_PG~P~SRG 
PPG  PI~;R  PGNAG  IRGPmPI~Y~ASIPYNC.,~FPEPYVPESGPY 
QPEGEPPIVPMESERREDEYEDYGVEMHSPEYPEHMRWKRGLSRKAKRKP 
Figure 3. Translated  sequence of the carboxyl end of o~ I(XII) con- 
tains a portion of the COLI domain and all of  the NCI domain. The 
open triangle  denotes the junction of these domains.  The location 
of cysteinyl residues  presumed to be involved in interchain  cross- 
linking  are located  near the COL1-NCI junction (asterisks).  The 
peptide  sequence from within the NC1 domain that was selected as 
target for monocional antibody production is shown (solid under- 
line).  The four methionyl residues  (e) are shown, one within  the 
COL1 domain and three within  the NCI domain. As described in 
the text,  amino acid sequence analysis  of cyanogen bromide pep- 
tides  purified  by affinity chromatography with the antibody 75d7, 
gave a  sequence of 20 residues  in perfect agreement (except  for 
hydroxylation of susceptible  prolyl [P] and lysyl [K] residues) with 
the DNA-derived sequence (dashed underline). 
at the carboxyl end of od(XII) chains, believed to be involved 
in interchain  disulfide  bonding.  Immunoblots of SDS gels 
with cyanogen bromide extracts of tendons should, therefore, 
show a  positive band at "~11 kD (reduced).  A  nonreduced 
sample should show a  positive band in a  higher molecular 
mass region. As shown in Fig. 4, the immunoblotting results 
with 75d7 are consistent with these predictions. In a reduced 
sample the antibody recognizes a major band at 11 kD, and 
this band is  (as predicted)  sensitive to treatment  with bac- 
terial collagenase. In an unreduced sample 75d7 recognizes 
Figure 2.  Immunoblotting analysis  of SDS polyacrylamide gels of 
1 M NaCi extract of day-17 chick tendons reveals an immunoreac- 
tive polypeptide migrating with an apparent molecular mass of 220 
kD  under  reducing  conditions.  Lanes  1-4  were  stained  with 
Coomassie, lanes 5-7 were transferred  to a PVDF membrane and 
immunostained  with the antibody 75d7. The positions  of globular 
molecular mass markers are indicated  on the right.  Lanes 1 and 5, 
1 M NaC! extract of tendons.  Lanes 2 and 6, extracts digested  with 
bacterial  collagenase for 5 h at 37°C.  Lanes 3 and 7, collagenase 
buffer  and  temperature  controls.  Note the collagenase sensitive, 
75d7 immunoreactive,  220-kD polypeptide.  In addition  there is a 
very high molecular mass immunoreactive band which appears to 
migrate with proteins  >300 kD, which may represent  a nonreduc- 
ible cross-link of otl(XII) chain to another molecular component. 
Figure 4. Gel electrophoresis and immunobloning of the CNBr di- 
gest of crude type XII collagen. Wells 1 to 4 were loaded with 40 
/~g  of the  digest.  The  samples  were  reduced  with  ~-mercapto- 
ethanol  (fl-SH) and digested  with collagenase (C'ase) as noted un- 
der the figure. After electrophoresis,  lanes 1 to 4 were blotted and 
reacted  with  the antibody 75d7. Lane 5 shows CNBr peptides  of 
type I collagen used for molecular mass determination  and stained 
with  Amido black.  As noted  in the text,  both unreduced and re- 
duced immunoreactive CNBr fragments  are sensitive  to bacterial 
collagenase (lanes  2 and 4). 
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These bands are also sensitive to treatment with bacterial 
coUagenase.  Additional support for this conclusion that the 
cyanogen bromide  fragments  recognized  by  75d7  indeed 
contain the predicted portion of al(XII) chains, comes from 
amino acid sequence analysis as described elsewhere (4). 
Unreduced cyanogen bromide fragments, purified by affinity 
chromatography on a column containing the antibody 75d7, 
separated by SDS gel electrophoresis and electroblotted onto 
a PVDF membrane gave a single amino-terminal amino acid 
sequence, in perfect agreement with the sequence predicted 
from the cDNA with cyanogen bromide cleavage at residue 
139  (Fig.  3)  (4).  Collagenase treatment of the unreduced 
fragment  should  result  in  an  epitope-containing  peptide 
migrating below 10 kD. Why no reactivity with the antibody 
is seen in Fig. 4, lane 2 is yet unclear. The faint immunoreac- 
tive band migrating above the major ll-kD band in Fig. 4, 
lane 3  may represent the product of incomplete cyanogen 
bromide cleavage. 
Immunolocalization of 73/pe XII Collagen in 
Embryonic Tissues 
Immunofluorescence with 75d7  demonstrates the type XII 
antigen to be prevalent within dense connective tissues, which 
contain type I collagen (Figs. 5-7).  Tissues most strikingly 
positive for type XII collagen include tendons, ligaments and 
dense connective tissue associated with perichondria, and 
periostea. These are tissues which also are immunoreactive 
with antibodies against type I collagen (compare Fig. 5, A 
with C). Type I collagen staining, however, is not always as- 
sociated with staining for the type XII antigen. Smaller con- 
nective tissue septa in striated muscle (endomysium) (Fig. 5 
A) or loose connective tissues which stain with moderate in- 
tensity with type I antibodies do not stain for type XII (Fig. 
5 C). Also, although periosteum and endosteum are positive 
with 75d7 (Fig. 6), bone matrix is negative. Around tissues 
that contain types II (Fig. 5 B) and IX (Fig. 5 D) collagens 
there is an interesting complementarity to the staining pat- 
terns seen with type IX and XII antibodies (Fig. 5, C and D). 
For example, in the fibrocartilagenous intervertebral disk, 
type IX antibodies stain the central region with the highest 
intensity (Fig. 7 B), while 75d7 stains mostly the periphery 
(Fig. 7 A). 
Discussion 
Monoclonal Antibody against 1~e XII Collagen 
Type XII collagen was recently identified on the basis of the 
isolation of the eDNA pMG377 from an embryonic chick 
tendon eDNA library (6). Sequencing of this clone indicated 
that it encodes the carboxyl region of a polypeptide which 
is in part similar in sequence to type IX collagen chains. The 
structure of the peptide,  which was given the designation 
Figure 5. Cryostat sections of 15-d embryonic chick sterna immunostained  with monoclonal antibodies against types I (A), II (B), IX (D), 
and XII (C) collagens. Note that cartilage matrix shows  positive staining for types II and IX collagens, while perichondrium and attached 
ligament  are positive for types I and XII collagens. Note also that thin septa in striated muscle are positive for type I (A, arrows)  but negative 
for types II, IX, and XII collagens. 
The Journal  of Cell Biology,  Volume 109, 1989  942 Figure 6. Cryostat sections through a long bone (phalange) of a 19-d-old chick embryo, stained with the monoclonal antibody against type 
I collagen (B) and type XII collagen (C).  Note the positive staining of tendon (/arge arrow), periosteum (open arrows), and the lining 
of internal cavities (small arrows). Note that the bone matrix (the inner surface indicated by triangles) is positive for type I but negative 
for type XII. Toluidine blue stained section (A). 
od(XlI), prompted the prediction that it is part of a molecule 
containing short triple-helical domains and that pepsin ex- 
tracts of chick embryonic tendons therefore should contain 
triple-helical pepsin-resistant fragments derived from type 
XII collagen. Isolation of such fragments has indeed been 
reported by Dublet and van der Rest (3), and amino acid se- 
quencing of a  tryptic peptide from one of the  fragments 
shows complete identity with the pMG377-derived sequence. 
Therefore, the al(XII) collagen gene is expressed not only 
on the mRNA level  (as  shown by our ability to isolate a 
cDNA clone) but also on the protein level in embryonic ten- 
dons.  However,  isolation of pepsin-resistant  triple-helical 
fragments of type XII collagen from embryonic tendons (3), 
although providing evidence for the existence of the protein 
in this tissue, unfortunately does not provide information 
about the size of cd(XII) and distribution of the protein in 
different tissues and organs. 
We  describe  here  for the  first time  the  preparation  of 
monoclonal antibodies against type XII collagen and the use 
of the antibodies for immunoidentification of the protein in 
tissues and tissue extracts. The antibody 75d7 was elicited by 
injecting a synthetic peptide into mice and the results of the 
Western blotting and affinity chromatography/amino  acid se- 
quencing clearly demonstrate that it reacts with type XII col- 
lagen in embryonic tendons. 
Immunofluorescence studies with 75d7 show that type XII 
collagen is found within type I collagen containing structures 
such as tendon, ligament, perichondrium, and periosteum 
(Figs. 5-7).  However,  type XII collagen staining is clearly 
not associated with all type 1-containing structures. As men- 
tioned above,  connective tissue septa in striated muscle or 
loose connective tissue which stain with moderate intensity 
with type I antibodies do not stain for type XII (Fig. 5, A and 
C). In addition, as shown in Figs. 5 and 7, cartilage and bone 
matrix appear negative with the 75d7 antibody. We cannot, 
at present, rule out the possibility that type XII collagen is 
present in cartilage and bone, but not detected by staining 
with 75d7 because of masking or degradation/modification 
of the  epitope.  Future  biosynthetic  studies  with  isolated 
chondrocytes and osteoblasts should enable us to address this 
issue. It should be noted that al(XII) mRNA has been de- 
tected in tendon, sternal cartilage, and calvarial bone total 
RNA  preparations  by  ribonuclease protection  assays (6). 
Therefore,  a  combination of immunohistochemistry with 
75d7  and in situ hybridization with cd(XII) cDNA should 
also be useful in addressing the question of the level at which 
type XII collagen expression is regulated. 
The Molecular Structure of 7)~pe XII Collagen 
The amino acid sequence analysis of disulfide-bonded, cy- 
anogen bromide fragments of type XII collagen, purified by 
affinity chromatography on a column containing the mono- 
clonal antibody 75d7, demonstrates that the carboxyl region 
of type XII collagen can be isolated with cyanogen bromide 
(as  predicted  from  the  cDNA  sequence)  as  a  disulfide- 
bonded fragment of,~ 30 kD (4). Since sequence analysis of 
the 30-kD components indicates a single, unique sequence 
and 75d7 reacts with a peptide of 11 kD after reduction, it 
has been concluded that type XII molecules are homotrimers 
composed of three cd(XII) chains (4). 
This conclusion leaves open the question of why the un- 
reduced carboxy-terminal cyanogen bromide peptide of type 
XII collagen migrates as a cluster of multiple sharp bands on 
SDS gels (Fig. 4).  Since sequence analysis of the peptides 
gave  no  indication  of a  sequence  other  than  the  unique 
Sugrue et al. Type Xll Collagen  943 Figure 7. Cryostat sections cut longitudinally 
through two cervical vertebrae of a 15-d-old 
chick embryo. (A) Immunostaining with the 
75d7 antibody. Note staining of the periphery 
of the intervertebral disk (white arrows), the 
faint staining of the center of the disk (open 
arrow) and the intense staining of the peri- 
chondrium  and longitudinal ligaments. (B) 
Immunostaining with  monoclonal antibody 
against type IX collagen. Note staining of the 
vertebral bodies and the center of the inver- 
tebral disk (open arrow). The periphery of 
the disk (white arrow) shows faint staining. 
od(XII) derived sequence (4) and all the bands also reacted 
with the antibody 75d7 (Fig. 4), microheterogeneities at the 
amino end are unlikely. However, there is the possibility of 
incomplete cyanogen bromide cleavage at the more carboxyl 
methionyl residues at positions 40, 24, and  15, Incomplete 
cleavage would result in  a  slightly larger immunoreactive 
peptide(s). In fact, a faint immunoreactive band at 14 kD can 
be seen in Fig. 4, lane 3. Obviously, disulfide-bonded trimers 
composed of complete and incomplete CNBr-cleavage prod- 
ucts could produce the cluster of peptide bands seen under 
nonreducing conditions. 
The nucleotide sequence of the cDNA pMG377 showed 
that the carboxyl triple-helical domain of od(XII) chains is 
quite  similar  to that of od(IX) collagen chains.  Sequence 
analysis of additional cDNA clones (unpublished data) dem- 
onstrates also that a portion of the amino terminal nontriple- 
helical domain of cd(XII)  has  a  high degree of sequence 
similarity with the corresponding domain  in the cartilage 
form of cd(IX). However, despite these similarities there are 
also clear differences between types IX and XII collagens. 
First,  as  demonstrated by the Western blotting data here, 
od(XII) chains are about twice the size of od(IX) chains. As 
shown elsewhere (4), this size difference is due to the pres- 
ence of a much larger (190 kD) amino-terminal nontriple he- 
lical domain on od(XII) than on od(IX) chains (25 kD) (20). 
Second, while type IX collagen chains contain three triple- 
helical domains, the al(XII) chain contains only two. Third, 
type IX collagen contains three genetically distinct subunits, 
and one of the chains contains a covalently attached chon- 
droitin and/or dermatan sulfate chain (8, 10, 14). In contrast, 
type XII molecules are most likely homotrimers and do not 
appear to contain chondroitin or dermatan  sulfate chains, 
since treatment with chondroitinase ABC does not change 
the electrophoretic migration of ed(XII) chains (4). 
The Functional Role of I~/pes IX and XII Collagen 
Is this report on the presence of type XII collagen in type 
The Journal of Cell Biology,  Volume 109, 1989  944 -I-containing collagen  structures another example of mixed 
(heterotypic) collagen fibrils? There are several reports (1, 2, 
9,  15) that indicate the existence of mixed fibrils containing 
types I and III collagen,  types I and V  collagen,  and types 
II and XI collagen. However, whereas types I, HI, V, and XI 
collagens are structurally similar, the multidomain collagen 
XII is structurally distinct from fibrillar collagens. The func- 
tion of this collagen must therefore be different from that of 
fibrillar collagens. Obviously, the data presented here do not 
allow us to define this function.  However,  we hypothesize 
that type XII collagen may be associated with type I contain- 
ing fibrils through the triple helical "tail; similar to the as- 
sociation between type IX collagen  and type II containing 
fibrils in cartilage. Indeed it has been demonstrated that type 
IX collagen molecules are associated with the surface of car- 
tilage fibrils (22), become covalently cross-linked to type II 
collagen (5, 21), and project a large globular domain attached 
to a triple-helical  arm into the matrix (22).  Our hypothesis 
is based on the genetic and structural similarities  between 
t~I(IX)  and  cd(XII).  These  similarities  include  a  similar 
carboxy-terminal  triple-helical  domain with two imperfec- 
tions in the GIy-X-Y structure (6,  17), and an exon structure 
at the 3' end of the od(XII) gene that is similar to that of the 
al(IX) gene (6,  12). The monoclonal antibody we have de- 
veloped against type XII collagen should prove useful in fu- 
ture studies to find out whether this hypothesis is correct. 
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